سایت خبری تحلیلی کسب و کار استارت آپ | کارآفرینی | دانش بنیان | اقتصاد
But that hasn t been enough to satisfy shareholder activists like carl ichan, who has criticized forest laboratories plans for dealing with the expiration of the lexapro patent and is reportedly planning to try to get several directors ousted from the pharmaceutical company s nine-member board at forest s annual …
مطالعه بیشتر